According to the research report titled ‘Global Biologics Safety Testing Market - Analysis By Product, Test, Application, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)’, available with Market Study Report, global biologics safety testing market was worth USD 3463.90 million in 2020 and is anticipated to showcase lucrative growth trends between 2021 and 2026.
 

Growth in biotechnology and pharmaceutical industry due to the government support, increasing investments for research & development in life science sector, and rising number of drug launches are the major factors driving the growth of the global biologics safety testing market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3578559/
 

Additionally, growing prevalence and enormous economic burden of chronic diseases, alongside legislative assistance for advancement of biologics & its safety are augmenting the market outlook.
 

However, stricter government regulations for endorsement of biologics, along with high costs associated with the medication are the factors restraining the growth of worldwide biologics safety testing market.
 

Based on products, the market is segmented into services, high kits & reagents, and instruments. Among these, high kits & reagents segment held a considerable industry share in the recent past, owing to repeated purchase of kits and reagents, along with rising adoption of kit-based testing.
 

Speaking of applications, global biologics safety testing industry is divided into vaccine & therapeutics, gene therapy, and blood & blood-based products including others. Moving on to test ambit, the marketplace is categorized into bioburden tests, sterility tests, adventitious agent detection tests, and endotoxin tests among others.
 

Geographically, Europe, North America, and Asia Pacific are the key contributors to the overall biologics safety testing industry value.
 

As cited in the report, North America held a significant market share in 2020 and is expected to record impressive growth graph over the forecast duration, owing to the factors like increasing research & development in life sciences, rise in pharmaceutical sector, along with increasing investments in biotechnology.
 

Key contenders in worldwide biologics safety testing industry include Eurofins Scientific, Maravai Life Sciences Inc., Charles River Laboratories International Inc., Samsung Biologics, Thermo Fisher Scientific, The Merck Group, The Sartorius Group, WuXi AppTec, SGS S.A., and Lonza Group AG.